KRYSTAL FAIL: Open Payments
NPI 1073185153 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 41 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $195 · 2025 $893
Food & beverage: $848Education: $45
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $286 |
| AstraZeneca Pharmaceuticals LP | 8 | $151 |
| Lilly USA, LLC | 7 | $145 |
| Axsome Therapeutics, Inc. | 3 | $80 |
| Ardelyx, Inc. | 2 | $40 |
| PFIZER INC. | 2 | $38 |
| Novo Nordisk Inc | 2 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
Products named: BOTOX, AIRSUPRA, MOUNJARO, Auvelity, VRAYLAR, FARXIGA, IBSRELA, QULIPTA.
Industry payments across GA — which companies pay providers there.
